Back to search
Scientific Name: Gilteritinib
Brand Name: Xospata
Company Owner: Not Available
Mechanism Of Action Gilteritinib is a potent selective inhibitor of both of the mutations, internal tandem duplication (ITD) and tyrosine kinase domain (TKD) , of the FLT3 receptor.
Description of the Drug: Gilteritinib is an AXL receptor tyrosine kinase inhibitor used to treat relapsed or refractory acute myeloid leukemia.
Protein Data Bank:
Source: DrugBank Online – Retrieved 2023-01-23 from